Therapeutic agent for sleep apnea

摘要

PCT No. PCT/JP90/00947 Sec. 371 Date Mar. 8, 1993 Sec. 102(e) Date Mar. 8, 1993 PCT Filed Jul. 25, 1990 PCT Pub. No. WO92/01448 PCT Pub. Date Aug. 6, 1992.Administration of ubidecarenone is effective for the therapy of sleep apnea. It is given at a dose of 1-3,000 mg per day in adults. It is especially effective to administer ubidecarenone to the patient before bed at a dose of 2-50 mg.